This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management

Authoring team

General approach:

  • elimination - gastric lavage with suitable airway protection should be considered up to 24 hours after ingestion. In children, consider emetics unless unconscious, in which case, perform lavage
  • give activated charcoal, 50 g, down lavage tube after lavage, or orally after emesis
  • take bloods for full blood count and electrolytes, with salicylate and glucose levels, and arterial blood gases
  • ensure adequate fluids / electrolytes with special attention to the need for:
    • intravenous potassium to prevent hypokalaemia
    • intravenous dextrose to prevent hypoglycaemia.
    • intravenous vitamin K to correct hypothrombinaemia
  • monitor urine output with urinary catheter
  • ideally, dehydration should be corrected with the aid of central venous pressure measurements because of the risk of cerebral and pulmonary oedema

Subsequent management depends on the degree of poisoning:

  • mild poisoning - adequate treatment is provided by fluid and electrolyte replacement
  • moderate poisoning - requires forced alkaline diuresis. This is at levels of salycilate of 500 mg per litre and over.
  • severe poisoning, levels of 750 mg per litre and over - consider for haemodialysis or haemoperfusion. May also require intermittent positive pressure ventilation and pulmonary artery wedge pressure measurement

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.